Those with severe kidney disease should also use berberine cautiously and under medical supervision, as specific guidance is limited given berberine's status as a supplement rather than a regulated pharmaceutical
To date, dulaglutide, semaglutide, and tirzepatide have been the three predominant GLP-1 therapeutics employed in the treatment of T2DM, and their applications have been broadened to include weight management
If that lighter, natural approach is what you are after, the key is choosing a well-made supplement and setting realistic expectations
In our study, we show that GLP-1-RAs are superior to UCWM both with respect to the extent of weight loss and the proportion of patients achieving the recommended 10% weight loss, highlighting the potential of concomitant pharmacological treatment for weight management in IIH
Chen S, Zhou M, Sun J, Guo A, Fernando RL, Chen Y et al (2019) DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
(Find more information here.) Whats Ahead in 2025